Decera Clinical Education Infectious Disease Podcast9 Mar

Managing CMV Risk in HCT Recipients: Optimizing Transplant Outcomes Through Contemporary CMV Management

Cytomegalovirus (CMV) infection is one of the most significant infectious complications after hematopoietic cell transplant (HCT). In this podcast, featuring curated audio from a live satellite symposium, experts Roy F. Chemaly, MD, MPH, FIDSA, FACP, FESCMID and Marcus Pereira, MD, MPH, FAST, discuss the burden of CMV in HCT recipients and explore strategies effectively identify and monitor high-risk patients. Topics include:

Epidemiology of CMV among HCT recipients
Direct and indirect effects of CMV after HCT
Dynamics of risk factors for CMV infection
Strategies for prevention of CMV infection

To view the full educational program and download the accompanying slides, visit our website:
https://bit.ly/4lfrDTT

Presenters:

Roy F. Chemaly, MD, MPH, FIDSA, FACP, FESCMID
Professor and Chair
G.P. Bodey, Sr. Distinguished Professorship in Infectious Diseases
President, The International Immunocompromised Host Society (ICHS)
Director, Clinical Virology Research
Department of ID/IC/EH
UT MD Anderson Cancer Center
Houston, Texas

Marcus Pereira, MD, MPH, FAST
Associate Professor of Medicine
Director of Clinical Services, Division of Infectious Diseases
Medical Director, Transplant Infectious Disease Program
Columbia University Irving Medical Center
New York, New York

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(509)

A Path to Protection Podcast: Purposeful Solutions to Power Up Influenza Vaccine Uptake

Currently, annual influenza vaccination is recommended for everyone 6 months of age or older who do not have a contraindication, but vaccine uptake was suboptimal among adults and children during the ...

17 Aug 35min

Screening for and Treating Substance Use Disorder, Depression, and Anxiety in Routine HIV Care

Mental health care is HIV care! It is reasonable and feasible to screen for and treat mild to moderate cases of substance use disorder, depression, and anxiety in HIV primary care. Featuring audio fro...

5 Aug 1h 3min

Next Up in PBC Podcast: Updates From EASL 2026

With this podcast, featuring audio from a Medical Minute webcast, expert faculty Maria Londoño, MD, PhD, discusses how recent clinical trial and real-world data can improve treatment plans for patient...

4 Aug 15min

Beyond the “Pneumonia Shot”: Explaining the Full Benefits of Pneumococcal Vaccines to Patients

Just as pneumonia isn’t “just a cold,” the pneumococcal vaccine does much more than just protect yourself or your child against pneumonia. Listen in and learn from experts Robert H. Hopkins, Jr., MD, ...

1 Jul 21min

Heading Off Misinformation and Disinformation: Pressure Points in Pediatric Vaccines Podcast 3

In the final episode of a 3-part series, featuring audio from a live symposium, experts Mary Koslap-Petraco, DNP, PPCNP, CPNP, FAANP, Patricia Stinchfield, MS, RN, PNP, and Jennifer M. Walsh, DNP, CPN...

18 Jun 23min

Countering Myths and Mixed Messages: Pressure Points in Pediatric Vaccines Podcast 2

In the second episode of a 3-part series featuring audio from a live symposium, experts Mary Koslap-Petraco, DNP, PPCNP, CPNP, FAANP, Patricia Stinchfield, MS, RN, PNP, and Jennifer M. Walsh, DNP, CPN...

18 Jun 21min

Don’t You Wish You Pneumo? Why We Continue to Update Our Pneumococcal Vaccine Strategy

Pneumococcal vaccine recommendations are constantly evolving to respond to shifting patterns of infections, which is a good thing. However, the nuances can be complicated to explain to patients. Liste...

5 Jun 17min

DeLIVERing Prevention Podcast: Optimizing Uptake of Hepatitis A and B Vaccination

Viral hepatitis is an ongoing public health threat, despite the long-standing availability of effective vaccines for hepatitis A and B. Here, experts Paul Kwo, MD, Jewel Mullen, MD, MPH, MPA, FACP, an...

1 Jun 37min